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Abstract 
Metabolic Environment and Cellular Signaling in Haematopoietic Stem Cells 
and Progenitor Cells  
The University of Leipzig, Dissertation 
58 P., 77 Ref., 59 Abb., 3 Appendix 
Haematopoietic bone marrow is functionally divided into areas supporting the maintenance 
and self-renewal of stem cells on the one hand and the proliferative differentiation of 
progenitor cells on the other. It is proposed that this functional organization is determined 
not just by the signaling environment provided by the local presentation of growth factors, 
but also by metabolic variables such as glucose, nicotinamide (NAM) and osmolarity, which 
may vary with the position relative to arterioles and sinusoids. A key issue here is whether or 
not variations in the metabolic environment of a progenitor cell alter the response of that 
cell to growth factors. 
Firstly, it was found that the simple addition of NAM in the absence of added myeloid 
growth factors is sufficient to support differentiation of multipotent progenitors to 
granulocyte-like cells, demonstrating that the nutrient composition of medium can in 
principle influence the balance between self-renewal and differentiation. 
Secondly, a relatively small increase in the salt concentration in the growth medium 
increased both the proportion of early progenitors and the level of JAK2-STAT5 signaling via 
the IL-3 receptor, which is associated with self-renewal rather than differentiation. This 
shows that physico chemical conditions can also influence the differentiation of haematopoi-
etic progenitor cells. 
Thirdly, decreasing the glucose concentration over the range 5 – 0.1mM progressively 
decreased the pERK1/2 response to IL-3, while pSTAT5 levels actually increased under low 
glucose. An investigation of the mechanism by which JAK-STAT activity is maintained under 
low energy conditions revealed a requirement for Nme2, a nucleotide diphosphate kinase 
that is differentially expressed in progenitor cells and that has been implicated in myeloid 
leukemia. Based on these results, it is proposed that a specific association between Nme2 
and the JAK2 STAT5 pathway enables local regeneration of ATP and maintenance of 
signaling. 
This work demonstrates how the nutrient and physico-chemical environment can indeed 
affect the self-renewal versus differentiation of haematopoietic progenitor cells in vitro, 
consistent with the proposed existence of metabolic niches in vivo that contribute to the 
organization and control of haematopoiesis. The identification of Nme2 as a key link 
between metabolic and signaling activities should enable more detailed analysis of these 
relationships in the future. 
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1. Introduction and literature review 
1.1 Haematopoietic stem cells and progenitor cells 
The adult human blood system is maintained by replacement of more than 1011 cells per day 
through continuous haematopoiesis: A hierarchical differentiation and proliferation system 
in the bone marrow. At the top of the hierarchy are haematopoietic stem cells (HSCs) that 
cycle slowly to generate on average one replacement HSC and one multipotent progenitor. 
The multipotent progenitors then proliferate more rapidly, generating daughter cells that 
follow programs of commitment to the lymphoid, myeloid or erythroid lineages. Under some 
conditions (during development or after damage), the pool of HSCs can be increased by 
symmetric divisions in which one stem cell produces two (Nakamura-Ishizu et al. 2014; Ng 
and Alexander 2017; Pinho and Frenette 2019).  
 
 
Fig 1-1 Summary of haematopoietic hierarchy and stem cell fate. 
It is important to understand the ways in which this process is regulated to maintain a 
balanced output throughout life, even when the demand for particular cell types changes 
due, for example, to infection, injury or simply change of altitude. A detailed understanding 
of these control mechanisms will be required for the efficient recognition and treatment of 
haematological disease. Most attractive would be the possibility of amplifying HSCs ex vivo, 
since the number of HSCs is a limiting factor in some transplantation strategies (e.g. using 
umbilical cord blood stem cells for adults, or repeating transplantations from the same 
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donor). Also, the quiescent or slow-cycling status of the earliest stem cells limits the 
efficiency of viral gene therapy. The efficient generation of erythrocytes and granulocytes in 
vitro is another important goal, as this could offer a way of producing well-characterized, 
safe cells for therapeutic applications by “cell-pharming” in bioreactors rather than relying 
on blood donations. Finally, a characterization of the mechanisms controlling normal 
haematopoiesis promises to reveal valuable information about the differences between 
normal cells and their leukemic counterparts, properties specific to leukemic cells being 
potential targets for new and selective diagnostic/therapeutic approaches.  
With these aims, there has been much interest over the years in characterizing the 
mechanisms of haematopoiesis. Most of the effort has been spent on isolating and 
characterizing a wide range of growth factors that have specific effects on stem/progenitor 
or differentiating cells. Some of these factors, most notably erythropoietin (EPO), 
thrombopoietin (TPO) and granulocyte colony stimulating factor (G-CSF) are in widespread 
use to boost the numbers of erythrocytes, platelets or granulocytes in patients, although use 
of the same factors in bioreactors to drive production of therapeutic cells in vitro has proven 
very challenging. Other factors (including stem cell factor (SCF), Flt-3-Ligand, Wnt3a, 
Hedgehog and a range of interleukins) clearly have effects on stem/progenitor cell 
compartment but have not been translated into widespread clinical benefit (Lento et al. 
2013; Lampreia et al. 2017; Xu et al. 2018). One of the reasons for the limited impact of 
growth factors in vitro is that their action may well rely on having an appropriate metabolic 
environment (Cross et al. 2008). Both supportive growth factors and the appropriate 
metabolic environment are supplied locally by stromal cells in the bone marrow (Kohli and 
Passegué 2014). The fate of a stem/progenitor cell is then most likely decided both by the 
growth factors that are present and the metabolic conditions in which that signal is seen. In 
order to understand the control of haematopoiesis, it is therefore likely to be informative to 
focus on the link between metabolism and signaling in stem and progenitor cells. 
1.2 Role of metabolism in normal and leukaemic HSC and progenitor cells 
The stroma that supports the various stages of blood cell production is formed by a number 
of interacting cell types including mesenchymal stromal cells, osteoblasts, adipocytes, neural 
cells, and endothelial cells of the arterioles and sinusoids (Kumar et al. 2018). Given the high 
level of biosynthetic metabolism occurring in the space between arterioles, sinusoids and 
bone surfaces, regional variations can be expected in the concentration of the substrates 
and products of metabolism such as carbohydrates, amino acids, fatty acids oxygen and 
carbon dioxide. This means that a haematopoietic cell is likely to be exposed to different 
cell-cell and cell-matrix contacts, growth factor signals and metabolites depending on its 
position in the marrow architecture. This raises the question of whether metabolic 
compartments within the marrow help to localize organize and regulate haematopoiesis.  
There are a number of indications that this is indeed the case. Firstly, although the 
consistency of haematopoietic marrow has made it difficult to define the complex 




distinct regions. For instance, HSCs tend to be located near to vessel walls or endosteal 
surfaces (Morrison and Scadden 2014),while erythropoiesis and megakaryopoiesis are 
associated with sinusoids and the production of granulocytes is associated with arterioles 
(Naito et al. 1992).  
Secondly, studies of haematopoietic cell metabolism reveal shifts in the pattern of activity 
and preferred substrates as stem cells progress through commitment and differentiation 
(Kohli and Passegué 2014; Agathocleous and Harris 2013). The current consensus is that 
quiescent stem cells rely largely on glycolysis to provide the energy that they require and 
that glycolytic metabolism is supported by the hypoxic environment of the stem cell niche. 
The hypoxia inducible factor HIF-1α is involved in the induction of genes required for 
glycolysis as well as the suppression of mitochondrial metabolism, hence limiting the 
production of reactive oxygen species (ROS) as a potentially damaging by product of 
oxidative phosphorylation (Simsek et al. 2010). In this way, the stem cell pool is protected 
from accumulating long term damage. As the cells become progressively more activated, 
mitochondrial metabolism is increased in order to provide the biosynthetic metabolism 
required for proliferation. In the early stages of activation, fatty acid oxidation (by which the 
mitochondria generate energy but no biosynthetic intermediates) has been shown to be 
necessary in order to prevent commitment and to maintain the stem cell phenotype in at 
least one of the daughter cells (Ito et al. 2012). Subsequent lineage commitment and 
differentiation involve the high level activation of mitochondrial metabolism with the 
associated generation of ROS (Fig1-2) and differential use of amino acid and carbohydrate 
substrates, glutamine being particularly important for erythropoiesis, while glucose appears 
to be the preferred substrate for myelopoiesis (Oburoglu et al. 2014; Billing et al. 2017). 
 
Fig 1-2 Changes in metabolism during stem cell commitment. 
 
 The fact that haematopoietic progenitors change both their location and their metabolic 
activity as they undergo commitment and differentiation is consistent with the idea that 
their fate may be influenced by their metabolic environment, which is defined not only by 
the local concentration of nutrients and waste products but also by physico-chemical 
parameters such as oxygen concentration, pH and osmolarity. Each of these is likely to vary 
with position in the marrow. While the effects of osmolarity on haematopoiesis have not 
been studied in any detail, it should be noted that the optimal osmolarity for the culture of 
haematopoietic cell lines (which at 300 to 320 mOsm/kg corresponds roughly to that of 




cultures. Here, a higher osmolarity of 350 mOsm/kg supports more robust activity and more 
stable cultures (Coutinho et al 1993).  
The proposed influence of cell metabolism on stem and progenitor cell fate raises the 
question of whether it is possible to influence fate using interventions that change the 
metabolic environment. In support of this, there have been a number of reports that the 
addition of nicotinamide (NAM, vitamin B3) selectively affects the fate of haematopoietic 
cells both in vitro and in vivo. NAM is the precursor of nicotinamide adenine dinucleotide 
(NAD+), a coenzyme with a wide variety of activities in both signaling and metabolism. NAM 
supplementation shifts the balance of macrophage differentiation (Weiss et al. 2015) and 
increases the granulocytic differentiation of the human HL60 myeloid leukemia cell line and 
of primary CD34+ stem/progenitor cells(Skokowa et al. 2009). This was found to involve the 
NAD+-mediated activation of sirtuin-1 and induction of the GCSF and GCSF-R genes, leading 
to an autocrine/paracrine support of granulopoiesis. NAM supplements given to healthy 
human volunteers also increased granulocyte output, so NAM has a pro-granulopoietic 
effect also under physiological conditions. NAM has also been reported to selectively 
preserve CD34+ cells and stem cell activity in umbilical cord blood mononuclear cells (Peled 
et al. 2012). The promotion of sirtuin (NAD+ dependent histone deacetylase) activity has 
been implicated in this effect, but the details of the mechanism and the relationship to the 
granulocyte differentiation effect remain unclear. However, the fact that NAM-derived NAD+ 
is also an essential cofactor in a wide range of metabolic processes and a substrate for 
signaling intermediates. (Fig 1-3) suggest that the effects on haematopoiesis may not be 
solely down to the activation of sirtuins, but could involve a combination of effects at the 
levels of metabolism, signaling and gene expression. The NAM response of haematopoietic 
progenitor cells therefore provides an opportunity to investigate more closely links between 
signaling and metabolism in the control of cell fate. 
 
Fig 1-3: NAM-derived NAD+ is involved in a variety of metabolic and signaling pathways as well as in the control 




The emerging role of metabolism as a determining influence on haematopoiesis raises the 
question of whether there are differences between normal and leukemic cells in this respect 
that may be used to target the treatment of leukemias. In general, leukemic cell populations 
tend to have either high glycolytic activity, in common with many solid tumors (Chen et al. 
2014), or high levels of fatty acid oxidation (Moreno 2015; Jones et al. 2018). However, 
although these activities may provide a growth and survival advantage to the bulk of the 
leukemic cell population, it is the small proportion of leukemic stem cells that are most 
relevant to long term prognosis and here it is still not clear to what extent the self-renewal 
of leukemic stem cells may differ from that of normal stem cells in terms of metabolic 
activity and requirements (Ito and Suda 2014; Stuani et al. 2019). 
1.3 Interaction between Signaling and Metabolism 
Although metabolic and signaling pathways have been analyzed largely independently in the 
past, there are three levels at which they may interact to coordinate cell responses. 
Firstly, metabolic enzymes can be activated or repressed in response to receptor-mediated 
signaling. Foremost among the signaling pathways linking to metabolism in this way is the PI-
3K-/Akt/mToR pathway which is activated by receptor tyrosine kinases and induces the 
expression of genes for glucose uptake and glycolysis (via activation on the hypoxia-inducible 
factor HIF-1α) and genes for the pentose phosphate pathway and lipid synthesis via the 
activation of sterol regulatory element-binding protein SREBP, (Yecies and Manning 2011). 
Secondly, these signaling responses can be modulated by nutrient sensors that take account 
of the availability of the metabolites and energy. For instance, the enzyme AMP-
responsive  kinase (AMPK) responds to the increase in AMP levels at low energy levels by 
inactivating enzymes required for biosynthetic pathways with high energy demand, but also 
targets transcription factors involved in signaling response (Mihaylova and Shaw 2011). 
Finally, since a number of key metabolites serve as substrates for regulatory modifications 
(phosphorylation, methylation, acetylation, glycosylation or ADP-ribosylation), it is feasible 
that these modifications themselves may be substrate-limited, thus linking signaling 
responses directly to the metabolic environment. In support of this principle, there is strong 
evidence that high levels of α-ketoglutarate contribute to the demethylating activity 
involved in maintaining potential in cultured pluripotent stem cells (Carey et al. 2014) . Here, 
it should be borne in mind that the culture of pluripotent stem cells in nutrient-rich media is 
non-physiological and pluripotency is a very short lived state in the physiological 
environment inside a pre-implantation blastocyst. In contrast, adult HSCs maintain their 
pluripotency in vivo over very long periods of low activity. In this respect, it is noteworthy 
that many of the cell-cell signals that are associated with the maintenance and amplification 
of HSCs during development or in the niche tend to trigger short and direct transduction 
pathways with few intermediates and a low energy requirement. The Notch Receptor, for 
instance, need only undergo proteolytic cleavage in order to create a transcription factor, 
while canonical Wnt signaling achieves a transcriptional response by reducing rather than 
increasing target (ß-catenin) phosphorylation. Once the cells leave the niche and are 




depend on the level of energy available and that the metabolic environment may in this way 
influence the balance between self-renewal and differentiation. Two signaling pathways of 
particular interest in this respect are the JAK-STAT and Ras-MAPK cascades. These pathways 
are commonly triggered by the same ligand-bound receptors but are associated with 
different effects.  
  
Fig 1-4  Potential connections between signaling and metabolism.  
 
1.4 Features of JAK-STAT5 and Ras-MAPK signaling 
The Janus kinase and Signal Transducer and Activator of Transcription 5 pathway (JAK-
STAT5) is the main pathway for self-renewal in normal and leukaemic HSC  is comparatively 
short, with the JAK-mediated phosphorylation of STAT5 converting it directly to a 
transcription factor (Aaronson and Horvath 2002; Schepers et al. 2012; Han et al. 2009). In 
contrast, the Ras-MAPK pathway (also known as the Ras-Raf-MEK-ERK pathway) which is 
ubiquitously involved in the regulation of cell proliferation, differentiation and death (Hsu 
et  al. 2007; Matsuzaki et al. 2000; Miranda et al. 2005; Pearson et al. 2009; Richardson et al. 
2015; Woessmann et al. 2004) involves a multifactorial kinase cascade and a correspondingly 







Fig 1-5 The JAK-STAT and Ras-MAPK pathways. 
 
1.4.1 JAK-STAT5 pathway 
 STAT5 is broadly expressed throughout the normal and leukaemic haematopoietic system 
(Han et al. 2009), where it can be activated by diverse cytokine and growth factor receptors 
including those of the interleukin 3 (IL-3) family, comprising IL-3 itself, IL-5 and  granulocyte 
macrophage colony stimulating factor GM-CSF; the common gamma-chain receptor family 
(IL-2, IL-7, IL-9, IL-12, IL-15); as well as a wide range of single chain receptors for EPO, TPO, G-
CSF, macrophage colony stimulating factor (M-CSF), SCF and many others (Ghanem et al. 
2017; Han et al. 2009; Wierenga et al. 2006).  In the vast majority of these cases, including 
that of the IL-3 receptor family, STAT5 activation requires the activation of a JAK kinase, 
which is recruited to the ligand-bound receptor following ligand binding and receptor 
autophosphorylation. JAK can then phosphorylate both the receptor at a separate site (to 
recruit STAT) and then STAT itself. Since phosphorylated STAT then merely dimerises to form 
a transcription factor, the energy input into the JAK-STAT pathway is relatively low (Fig 1-5). 
 
1.4.2 RAS-MAPK-ERK pathway 
The RAS-RAF-MEK-ERK pathway is a ubiquitous, multi-step pathway that is triggered by 
ligand binding to tyrosine kinase receptors and is involved in the regulation of cell 
proliferation, differentiation and death. The major components of the pathway include a 
small G protein (RAS) and a series of three protein kinases (RAF, MEK, ERK). Following ligand 
binding, dimerization and autophosphorylation, the phosphorylated receptor recruits an 
adaptor protein (Grb) which in turn interacts with the GTPase-activating protein (SoS). It is 
the SoS protein that is responsible for activating Ras by charging it with GTP. Activated Ras in 
turn activates Raf, which is the first in a cascade of kinases. The final cytoplasmic kinase 




subfamilies of MAPKs: the extracellular flag managed kinases (ERKs), the c-Jun N-terminal 
kinases (JNKs), and the p38 kinases (Cargnello and Roux 2011). The activated MAPK 
translocates to the nucleus where it activates transcription factors that regulate gene 
expression (McCain 2013). In the case of ERK1/2, the final targets in the nucleus include a 
range of transcription factors, such as Ets-1, c-Jun, c-Myc and NF-κB (Nakano et al. 1998). As 
summarized in (Fig 1-5), the Ras-MAPK pathway requires a complete kinase cascade which 
amplifies the signal at the cost of a high energy demand, while the JAK-STAT pathway 
involves just a single soluble kinase to activate transcription. Given that JAK-STAT5 activity In 
haematopoietic progenitor cells is associated with self-renewal (maintenance of the stem 
cell phenotype in at least one daughter cell) while Ras-MAPK signaling is more closely 
associated with proliferative differentiation. It is feasible that the balance of activity 
between these two pathways influences cell fate in response to available energy levels.  
 
1.5 The FDCP-Mix cell culture model  
The association of metabolism and signaling can be approached most directly in a 
haematopoietic progenitor cell culture system in which both the JAK-STAT and Ras-MAPK 
pathways can be activated by the same growth factor receptor stimulation. The murine 
Factor Dependent Cell Paterson Mixed Potential (FDCP-Mix) system offers precisely such a 
system. FDCP-Mix cells are karyotypically normal, non-leukaemic, multipotential progenitor 
cells that undergo differentiation into all myelo-erythroid lineages in the presence of 
suitable stroma or lineage-specific growth factors (Heyworth et al. 1995; Spooncer et al. 
1986). In the presence of high concentrations of interleukin 3 (IL-3), differentiation is 
blocked and the cells amplify as a population of self-renewing multipotent progenitors, 
although even in this state FDCP-Mix populations are heterogeneous, with 2-5% of cells 
being capable of initiating colonies in semi-solid medium. The continued culturing of the 
FDCP-Mix cells for more than 2 months can result in the loss of erythroid differentiation 
potential that is often followed by the acquisition of a pre-leukaemic transformed 
phenotype, increased clonogenicity and a complete differentiation block. For these reasons, 
it is routine procedure to work with FDCP-Mix cells within 2 months of thawing (Just et al. 
1993; Spooncer et al. 1986). The near-physiological properties of the FDCP-Mix cells during 
the early stages of culture make them a powerful model system in which to study the 
mechanisms of self-renewal and differentiation (Fairbairn et al. 1993; Pierce et al. 2002; 









1.6 Hypothesis and Aims 
Based on the reasoning outlined above, it was hypothesized that the control of self-renewal, 
commitment and differentiation of haematopoietic progenitor cells in response to 
haematopoietic growth factors can be influenced by the metabolic environment, which 
varies depending on the position in the bone marrow. In this way, haematopoiesis may be 
organized into compartments defined by the availability of substrates for catabolic (energy 
producing) and anabolic (biosynthetic) metabolism and cofactors, and by physicochemical 
parameters such as oxygen tension, pH, and osmolarity. Specifically, it was hypothesized 
that there is a bias towards JAK-STAT (self-renewal) signaling in low energy environments. 
The aims of this work were to test this hypothesis in the following ways: 
 To determine the effects of metabolic restriction and inhibition on the balance 
between JAK-STAT and Ras-MAPK signaling in multipotent progenitor FDCP-Mix cells 
responding to IL-3. 
 To examine the dependence of signaling on changes in osmolarity 
 To determine the effects of nicotinamide on the self-renewal and differentiation of 



















2. Material and Methods  
2.1Cell culture 
The FDCP-Mix Cell line (Spooncer et al. 1986) was cultured in a maintenance / self-renewal 
medium consisting of Iscove's Modified Dulbecco's Media (IMDM, PAN Biotech GmbH, 
Germany, cat. no. L-06-054-212-001, glucose and glutamine-free supplemented with 10% 
IMDM medium conditioned by the IL-3 producing murine myeloma cell X63AG8.653 
(Karasuyama and Melchers 1988), 20% horse serum (Gibco lot no. 818358), 5mM glucose 
(Sigma Aldrich, Germany cat no G7021-100G) and 2mM glutamine (Sigma Aldrich cat no 
G8540-25G). In some cases, 10U/ml recombinant mIL-3 (PEPROTECH cat no 210-33, USA) as 
used instead of IL-3 conditioned medium (cm). The osmolarity of the growth medium was 
measured using a cryo-osmometer (Gonotech, Germany) and adjusted to 320mOsm/kg 
unless otherwise stated. Cells were seeded at 6 x 104 per ml and passaged every 2 days to 
keep the cell density between 6 x 104 and 4 x 105 /ml. Depending on the requirements of the 
experiment, media were made with varying glucose concentrations (0mM to 10mM) and 
osmolarities (320, 340 and 360mOsm/kg) and were supplemented with metabolic inhibitors 
2 deoxyglucose (2DG, Sigma –Aldrich cat no D6134-1G) and/or rotenone (rot, Sigma-Aldrich 
R8875-1G), or nicotinamide (NAM, Sigma NO636-100G, USA) as described in the results 
sections.   
To differentiate the FDCP-Mix cells along myeloid lineages, self-renewing cells were 
harvested, washed twice in phosphate-buffered saline (PBS) to reduce the concentration of 
IL-3, then reseeded at 6 x 104 /ml into IMDM supplemented with 10% fetal bovine serum 
(FBS) plus 1u/ml recombinant murine IL-3 (PEPROTECH cat no 210-33, USA), 1000U/ml G-CSF 
(PEPROTECH cat no 210-23) and 50U/ml GM-CSF (PEPROTECH cat no 315-03). For erythroid 
differentiation, washed cells were seeded at 6 x 104/ml into IMDM supplemented with 10% 
FCS, 2U/ml mIL-3 (PEPROTECH cat no 210-33, USA), 3U/ml erythropoietin (EPO, PEPROTECH 
cat no 100-64, USA), and 0.2mM Hemin (Sigma-Aldrich H9039). Differentiation was assessed 
after 7 days of culture by FACS analysis of surface markers (see below) and by morphological 
examination of cytospun cells. 
2.2 Cytospins 
Cells (6x104/ml) were prepared for cytological examination by cyto-centrifugation onto pre-
labelled glass slides using a Hettich - Universal 16 cytospin. The dried and fixed cells were 
stained for 10 minutes in the dark in solution A for erythroid progenitors (100 ml) : 50 ml O-
Dianisidin 0.2 g /100 ml Methanol (Sigma Aldrich cat no . D9143) 10 ml Nitro ferri cyanide 
Na2Fe(CN)5 NO.H2O 1g/100 ml deionized water (Sigma Aldrich cat no. 228710) , 10 ml 30% 
H2O2  and 10 ml H20. Then, the slides were washed in running deionized water and 
transferred to solution B (May-Grünwald stain ROTH Art no . T863.2) for 5 minutes followed 
by a repeat wash in deionized water. Lastly the slides were stained with solution C (1:20 
Giemsa stain ROTH Art no . T862.1). Microscopical examination was done using Zeiss Vert.A1 




2.3 Colony-forming cell Assays  
FDCP-Mix cells (3.3x103 ) in 10ml  self-renewal complete media IMDM were mixed with 1ml 
melted 3.3% agar (BactoTMAgar Ref no.214010,France) to final concentration of 0.33% agar. 
The cells were then plated out of this mixture in to 3 well plate (3 mls per well). The plates 
were incubated in 5% CO2 in air at 37 °C for 7 days .The colony assessment was done at 20X 
magnification using  a Zeiss Vert.A1 microscope. The colony was recognized as a group of ˃ 
50 cells as is described by (Heyworth and Spooncer 1993).  
2.4Cryopreservation and thawing of cells 
FDCP-Mix cells that had been in culture for 2 days were spun down at 800xg for 10 minutes. 
Then, the cells were re-suspended gently to a final density of 2 x 106/ml in 90% HS and 10% 
dimethyl sulfoxide DMSO and transferred in 1ml aliquots to labelled cryopreservation vials. 
The vials were transferred to a “Mr Frosty” freezing container and placed at -80 °C overnight 
for slow freezing. On the following day, cells were transferred to the gas phase of liquid 
nitrogen for long term storage.  
For the thawing process, frozen vials were placed in a 37 °C water bath and agitated gently. 
As soon as the mixture was thawed, it was transferred immediately to a 50ml falcon tube. 
Ten ml of complete media was gently added drop wise over a period of 10 minutes to keep 
the osmotic gradient between the cell interior and exterior as constant as possible. Cells 
were left at room temperature for 10 minutes to recover. In the next step, the cells were 
spun down at 800xg for 10 minutes, the supernatant was removed and the cells were re-
suspended in 10 mls of maintenance medium and incubated overnight at 37 °C, 5% CO2. The 
next day, the dead cells were removed by density gradient centrifugation over Pancoll (PAN 
cat no P-04-60500, Germany) according to the manufacturer’s instructions. Finally the 
recovered cells were re-suspended at 6x104 /ml in maintenance medium and returned to the 
incubator. FDCP-Mix cultures were passaged every two days.  
2.5 Intracellular Phosflow analyses for pSTAT5 and pERK1/2 
To measure the pSTAT5 and pERK1/2 responses to IL-3 stimulation, FDCP-Mix cells were first 
washed with 1xPBS and incubated for 2 hours in medium without IL-3. At the end of this 
period, 100U/ml mIL-3 was added to all cultures except for the unstimulated control. After 
5-30 minutes (depending on the experiment), 5 X 105 cells were fixed with Lyse/Fix buffer 
(BD Phosflow™ Lyse/Fix Buffer 5X cat no. 558049, SanDiego,CA) for 10 minutes at 37°C and 
then immediately centrifuged at 800xg and washed with 4 ml 1XPBS. Cells were stained with 
Fixable Viability Stain 780 (BD Horizon™ cat no. 565388) according to the manufacturer’s 
instructions. Cells were washed 2 times with staining buffer containing 0.1%NaN3 (Applichem 
cat no.22628-22-8, Germany). Permeabilization was carried out with 1 mL BD Phosflow™ 
Perm Buffer III cat no.558050) on ice for 30 min. After washing with staining buffer, cells 
were stained with BD Phosflow™ Alexa Fluor® 647 Mouse Anti-Stat5 (pY694) clone 47 (BD 
Biosciences cat no. 612599) and BD Phosflow™ Alexa Fluor® 488 Mouse Anti-ERK1/2 




(Unstimulated W/O IL3) controls were used to set the gates. The isotype controls used were 
(Alexa Fluor 647 Mouse IgG1, κ (BD Biosciences cat no. 566011) and Alexa Fluor® 488 Mouse 
IgG1 κ (BD Biosciences cat no. 557721). Flow cytometry was performed on a FACS Verse 
(BD).  
2.6 Isolation and storage of human CD34+ stem and progenitor cells  
Umbilical cord blood donated for research purposes was obtained from Vita 34 AG, following 
informed consent of the parents. The blood was first transferred to a T75 culture flask, then 
diluted x2 with PBS. For each 40ml of diluted blood, a 50ml Falcon was prepared with 12ml 
Ficoll and up to 40ml of cell suspension layered carefully over the ficoll. Density gradient 
centrifugation was carried out for 35min at RT and 1000g without brake. The gradients were 
transferred carefully to the laminar flow box and each interphase of MNC was transferred by 
using a Pasteur pipette into one fresh 50ml Falcon. PBS was then added to each Falcon tube 
to 50ml to wash the remaining ficoll off the cells, and the cells recovered by centrifugation at 
1000g 10min RT (brake on). The supernatant was removed using a 25ml pipette, then each 
pellet re-suspended in 5ml PBS before pooling maximum 5 x 5ml into a single Falcon and 
repeating the PBS washing step. Each pellet was then re-suspended in 10ml PBS, and all 
suspensions pooled to a single Falcon. A small volume of suspension was removed for cell 
counting using a hemocytometer and the remainder centrifuged once again at 1000g for 10 
min at room temperature. The final pellet was re-suspended at a concentration of 107 cells 
per ml in PBS + 10% BSA on ice. When the cells were completely re-suspended, an equal 
volume of PBS + 10% BSA + 10% DMSO was prepared and added slowly, to give a final 
suspension of 5 x 106 cells/ml in PBS + 10% BSA + 5% DMSO on ice. The cells were then 
distributed to pre-labelled cryovials in 1 ml aliquots and placed directly into a Mr. Frosty 
(Thermo-Fisher, Germany) freezing container at 4oC. The Mr. Frosty was then placed in a -
80oC Freezer overnight before transferring the frozen cells to the gas phase of liquid 
nitrogen.  Upon thawing (described above) , the MNCs were cultured in serum free IMDM 
media with 50ng/ml SCF (PEPROTECH, cat no 300-07, USA), 50ng/ml TPO (PEPROTECH, cat 
no 300-18, USA) and 50ng/ml FLT-3(PEPROTECH, cat no 300-19,USA).The cells were 
incubated in 5% CO2 and 18%O2 at 37 °C overnight to recover. In some cases, CD34+ve cells 
were purified using indirect CD34 Microbead kit (Milteny Biotec , order no. 130-046-701, 
Germany). First, the MNCs cell number were determined then, following a centrifugation 
step at 300xg for 10 minutes, the cell pellets were re-suspended in 400μl staining buffer. 
After that, 100μl FcR blocking reagent was added then the CD34+ cells were indirectly 
magnetically labeled using 100μl hapten-conjugated primary monoclonal CD34 antibody. 
The cells were incubated for 15 mintues at 4°C. After a further centrifugation step at 300xg 
for 10 minutes, the cells were re-suspended in 400μl buffer and 100μl of anti-hapten 
MicroBeads were added and the mixture was incubated for 15 minute at 4 °C. Following 
another centrifugation step as described above, the cells were re-suspended in 500μl of the 
staining buffer. The cell suspension was loaded onto a MACS column which was placed in the 
magnetic field of a MACS separator. The magnetically labeled CD34+ cells were retained 




of CD34+ cells. After removing the column from the magnetic field, the magnetically 
retained CD34+ cells were eluted as the positively selected cell fraction. the experiments were 
performed and analyzed as is described in the results section 3.4 
2.7 Lentiviral backbone plasmid cloning, amplification, isolation and 
verification 
pGhU6 vector (provided by Merixtell Albrich-Jorda in Prague Institute of Molecular Genetics 
of the ASCR) was digested with the restriction enzymes XhoI and HpaI (New England Biolabs 
cat no. R01465 and R01055, respectively) overnight at room temperature. The digested 
plasmid DNA was run in 1.2% horizontal electrophoresis gel (Sigma life science cat no. 
A9539-500G) electrophoresis for 1:30 hours and the desired band was visualized and cut out 
under UV light imaging (Gene flash Syngene bio imagine). The digested plasmid was purified 
using a Gene jet extraction kit (Themofisher cat no K0691). 
An Nme2 shRNA synthetic oligo made by annealing the following primers (Biomers.net 
GmbH biopolymers Factory) was obtained from Dr. Enrica Bach, Department of Hematology, 






The annealed oligonucleotide has one HpaI-compatible blunt end (New England BioLabs 
R01055)-and one XhoI-compatible TCGA overhang (New England BioLabs R01465). The 
oligonucleotide dsNme2 2μl (50ng/ul) was ligated to digested pGhU6 1μl (35ng/ul)  using 
T4DNA ligase and T4 ligase buffer (New England BioLabs MO202S and BO202S, respectively) 
at 4°C  overnight then on the next day the mixture was heated at 65 °C to deactivate the 
ligase reaction. The ligation mix was used to transform, chemically competent one shot TOP 
10 E coli (Invitrogen Thermofisher cat no: C404010) according to the manufacturer’s 
instructions. The transformation mix was spread onto LB agar AMP (Lysogeny Broth (LB), 
1.5% agar containing 1:1000 of (100mg/ml) Ampicillin antibiotic (Carl Roth GmbH k0291+Go.
K , Germany). After overnight incubation, 5 colonies were picked and expanded overnight in 
LB AMP liquid medium. Plasmid DNA minipreps were prepared using a Qiaprep spin mini 
prep kit (Qiagen, cat no 27104/27106) according to the manufacturer’s instructions. The 
DNA concentration was determined by spectrophotometry (Theromscientific Nanodrop lite 
spectrophotmeter). The DNA sequencing was carried out in the Core Unit DNA Technologies, 
University of Leipzig Faculty of Medicine done using primers for the pGhU6 vector: 
psicoR  tgc agg gga aag aat agt agac and LOK.1 5’ hU6 promoter gac tat cat atg ctt acc gt 
(Biomers.net GmbH biopolymers Factory). Once the identity had been confirmed by 
sequencing (Fig 2-1), maxi prep DNA was prepared from a large scale culture (Qiagen 
plasmid plus maxi kit cat no 12963/12965, Germany) . The shNme and Empty vector DNAs 





















2.8 Lentivirus production and transduction  
In principle, a lentivirus expresses reverse transcriptase, which converts the viral RNA to 
double stranded DNA, and integrase, which integrates this viral DNA into the host DNA. 
Once the viral DNA is integrated into the host DNA, it replicates through the host genome. 
Lentiviral transduction is an efficient method for the distribution of transgenes to dividing 
and non- dividing mammalian cells (Elegheert et al. 2018). In the current study, a 3rd 
generation packaging system was used with two separated plasmids, the Group Specific 
Antigen/ DNA polymerase (gag/pol) and  the Vesicular Stomatitis Virus/glycoprotein G (VSV-
G).  
The lentiviral particles were produced in 293T fibroblast cells according to addgene protocol 
guideline (addgene 2016, 2019). The 293T cells (3.8×106) were seeded in a T75 flask in 15 ml  
Dulbecco's Modified Eagle's Medium DMEM , 10% v/v FBS and 4 mM L-alanyl-L-
glutamine).The cells were incubated at 37 ℃, 5% CO2  overnight then  gently the media was 
aspirated and changed with 10ml fresh DMEM complete containing 25 μM cloroquine 
diphosphate and incubated for 5 hours. Later the mixture of transfection plasmids was 
prepared as follows :  12μg packaging vector gag/pol (addgene cat no 12260) +1.4 μg VSV-g 
(addgene cat no 12260) + 15μg the previously described construct shNme2 or the empty vec
tor as control +1:1000 of 1mg/ml polyethylenimine PEI (Sigma Aldrich cat no 408727) in 2 ml
 Opti-MEM (Thermo-Fisher scientific cat no 31985070,USA). The ratio between PEI /Opti-
MEM and the vectors was 3:1. Then, the mixture was incubated for 20 minutes at RT. 
Thereafter, the transfection mixture was mixed dropwise to the Lenti-X 293T packaging cells 
and incubated overnight. On the following day the media was aspirated and replaced with 
fresh 15 ml DMEM complete followed by an overnight incubation. Next, the virus was 
harvested at 48, 72, and 96 hours post transfection and the Green Fluorescent Protein GFP 
fluorescence was evaluated using the (Zeiss Vert.A1) microscope. Eventually, the collected 
virus supernatants were centrifuged at 500xg for 5 mintues to pellet any packaging cells that 
were collected during harvesting. The viral supernatants were stored in small aliquots at -
80 ℃ freezer until the target transfection.           
For target cell transfection,  the standard polybrene (sigma cat no H268) spin centrifugation 
transfection protocol was used as it described by (addgene 2016, 2019). A pilot study was 
performed to optimize  the best  ratio of lentivirus and the media. The culture media were, 
IMDM, 10% HS, 10% cmIL3 for FDCP-Mix and RPMI, 10% FBS for K562. Polybrene 10μg/ml 
was added to both media . The ratio of 1:3 (virus:polybrene) produced the best transfection 
result for FDCP-Mix with 66% transfection efficiency for both the  control empty vector and 
shNme2 construct (700μl virus + 300μl DMEM complete/ polybrene media + 1000μl DMEM 
complete/ polybrene media with 2x105cell density) . The 6 well plates were centrifuged at 
1200xg at 30 oC for 90 minutes and the control FDCP-Mix, shNme2 FDCP-Mix and control 
K562 were incubated overnight in biosafety level 2 S2 incubator at 37oC 5%CO2 . On the next 
day the culture media was changed for fresh media and the cells were returned to the 




(Zeiss Vert.A1). As pGhU6 doesn’t contain a selectable antibiotic resistance marker, the 
FDCP-Mix that expressed GFP were FACS sorted in the Core Unit Fluoreszenz–Technologien 
(BD FACSAria II SORP). 
2.9 Gene expression analysis by (qRT-PCR)  
For determination of the expression of Nme2 (NDPKB) mRNA, 1X106 FDCP-Mix cells were 
lysed and RNA was extracted with the RNeasy Micro or Mini Kit (Qiagen cat no 74106 or 
74004) according to the manufacturer’s instructions. The RNA was eluted in a final volume of 
10 μl, which was reverse transcribed into cDNA using the Thermofisher high capacity RNA to 
cDNA kit (cat no 4387406), in a final reaction volume 20μl (10μl RNA + 2μl 10x RT buffer + 
0.8 μl 25x dNTP mix + 2μl 10x random primers + 3.2μl H2O + 1μl RNase inhibitor + 1μl 
Multiscribe reverse transcriptase). The reverse transcriptase reaction was carried out for 10 
minutes at 25oC then 120 minutes at 37oC, followed by a denaturation step for 5 minutes at 
85oC then cooled to 12oC before transferring to storage at -20oC. 
The quantitative measurement of Nme2 transcript was carried out using a SYBRgreen-based 
real-time quantitative PCR (Thermo Fisher cat 4368577)  run on an Applied Bioystems 7500 
Real time PCR machine. For each reaction, 2μl of the cDNA product was used in a final 
reaction volume of 25μl (9.5 μl H2O + 0.5μl each primer + 12.5μl SYBRgreen mastermix + 2μl 
cDNA).  Following activation of the polymerase at 95oC for 15 minutes, the PCR reactions 
were run for 45 cycles of 15 sec denaturation at 94oC, 30 sec annealing at 63oC, 35 sec 
extension at 72oC. Product melting curves were determined by denaturation at 94oC for 15 
secs followed by 30 secs annealing at 60oC and heating from 60oC to 95oC at 15 secs per 
degree. 
 
The mRNA expression for each gene was determined by analysis of triplicate samples in all 
cases. The obtained Ct average (MW) of the gene under consideration (nme2) was 
normalized to that of the household gene (rplp0) to obtain the ΔCt value. This was then 
compared to a control sample (e.g., untreated cell line or d0 of a time course) to determine 
how many times higher or lower the expression of a particular gene of a sample was 
compared to the control. 
Calculations: ΔcT nme2 = MW cT nme2 – MW cT rplp0 
ΔΔcT nme2 = ΔcT nme2 Probe - ΔcT nme2 Control 
X-fold Expression nme2 = 2-∆∆Ct nme2 
 
2.10. Flow cytometry analysis 
2.10.1. Cell surface staining  
Cells (5x105/ml) were washed with staining buffer (450ml distilled water, 50 ml 10X PBS 
Gibco PH7.4REF70011036, 2.5ml 0.5%FBS PAN Biotech GmbH cat no. P261109, 5ml 1% 
NaN3). The cells then were centrifuged at 800xg for 10 minutes, the supernatant removed 




minutes. Then, in prelabelled FACs tubes 2μl of each required antibody was added. The 
antibodies used in this study were: Pacific blue IgG2b isotype control clone RTK453, 
Biolegend cat no.400627; Pacific blue anti- mouse CD 117(c-kit) clone 2B8, Biolegend cat 
no.105820; PE rat IgG2a isotype control clone RTK2758, Biolegend cat no. 400508; PE rat 
anti-mouse CD71 clone R17217, Biolegend cat no. 113808; Alexa fluor647 rat IgG2a isotype 
control clone R35-95, BD cat no557690 and Alexafluor 647 anti-mouse Gr-1 clone RB6-8C5, 
Biolegend cat no 108418.  The cell suspensions were incubated with antibodies for 15 
minutes at room temperature in the dark. One ml of staining buffer was added and the FACs 
tubes were centrifuged 800xg for 5 minutes at 4°C. The supernatant was then removed 
carefully and the cells were re-suspended in 500μl staining buffer, then stored on ice until 
measurement. FACS analyses were carried out using a FACS Verse. 
2.10.2 Apoptosis analysis 
For discrimination of apoptotic, necrotic and dead cells both annexin V-FITC and propidium 
iodide were used. The apoptotic cells stain positively for Annexin V-FITC that binds to 
phosphotidylserine but are negative for propidium iodide. Dead cells stain with  Annexin V-
FITC and  PI, whereas viable cells are negative for both Annexin V-FITC and PI. Cells were 
stained according to Miltenyi Biotec protocol (Order no. 130-092-052). Total cells (5x105) 
were washed with 1X Binding buffer and centrifuged at 300Xg for 10 minutes and the pellets 
were suspended in 100μl 1X Binding buffer. Afterwards, 5μl of Annexin V-FITC were added 
and incubated for 15 minutes in the dark at RT. Next, the cells were washed by 1 ml 1X 
Binding buffer and centrifuged as previously mentioned. Subsequently, the cell pellets were 
re-suspended in 250ul 1X Binding buffer to which 2,5μl of (100μg/ml) PI were added 
immediately prior to analysis by flow cytometry (FACS Verse).     
2.10.3 Cell cycle analysis (NAM project) 
Cells were cultured in medium containing 0.03, 1, 5, or 10 mM NAM for 4 days. After the 
incubation period cells were centrifuged at 800xg for 10 minutes and the supernatant was 
removed. The cell pellets were re-suspended in 0.5 ml PBS/1mM EDTA. Cells were fixed 
overnight at 4°C with 1 ml cold 70% ethanol and stored at 4oC until analysis. For analysis of 
cell cycle, the cells were spun down at RT 800xg for 5 minutes, then the supernatant was 
carefully removed and the cells were re-suspended in 250μl PBS/1mM EDTA/RNase 
(10mg/ml) in a pre-labelled FACS tube. Finally,  1:100 of PI (1μg/μl stock solution) was added 
and mixed well then the cell cycle analysis was carried out with FACs verse. 
2.11 ATP Bioluminescence assay  
For ATP measurement, the ATP Bioluminescence assay Kit HS II (ROCHE cat no 11699709001, 
Germany) was used.  
Principally, in this technique, the main reagent (luciferase) from Photinus pyralis (American 
firefly) catalyses the following reaction: 




The resulting green light has an emission maximum at 562 nm. Given saturating amounts of 
luciferase and D-luciferin, the light output is directly proportional to the ATP concentration. 
In the current study, the cells (2x107) were lysed with 200μl lysis reagent. Thereafter, the 
cells were incubated for 5 minutes at RT followed by centrifugation at 10,000xg 
for 30 seconds. The supernatant was then transferred to a fresh microcentrifuge tube and 
kept on ice until ATP measurement. Next, 100μl from the sample supernatant or the ATP 
standard controls were transferred to the measuring tubes. Lastly, the tubes were uploaded 
to the luminuteometer LUMAT LB 9507 from (BETHOLD TECHNOLOGIES GmbH&Co.KG, 
Germany) to ATP The concentration was calculated using a log-log plot of the standard curve 
data.  
2.12 Statistical analysis 
Results are expressed as mean ± standard deviation. Statistical analysis was performed w 
using one-way analysis of variance (ANOVA) followed by Tukey multiple comparison tests. 






















Section I : Metabolic effects on signaling pathways in haematopoietic 
progenitor cells (Figures 3-1 to 3-6) 
3.1 Restricting the glucose available to FDCP-Mix cells affects the balance of 
JAK-STAT and Ras-MAPK signaling from the IL-3 receptor 
Preliminary experiments were performed to see whether establishing a low energy 
environment by simply lowering the amount of glucose in the culture medium affects the 
JAK-STAT (self-renewal) and MEK-ERK (differentiation) responses to IL-3 to the same extent, 
or whether reducing glucose supply affects the balance between these two pathways. FDCP-
Mix cells maintained under standard self-renewal conditions in the presence of high IL-3 
were washed and transferred for 2 hours to IL-3-free medium containing either 5mM or 
0.1mM glucose. At the end of this period, IL-3 was added back for a period of 10 minutes 
after which the cells were fixed and subject to phosflow analysis to assess the pSTAT5 and 
pERK1/2 responses. Test cultures were compared to identical control cultures which had not 
been re-stimulated with IL-3 (Fig 3-1). Consistent with the expected decrease in intracellular 
ATP levels, glucose restriction led to a sharp reduction in the pERK1/2 response. Surprisingly, 
the pSTAT5 response in the same cells was not merely maintained but was actually increased 
significantly following glucose restriction. This shows that the balance between signals 
associated with self-renewal and differentiation can indeed be affected by simple changes in 
the metabolic environment of the cells. 
 
Fig 3-1. Reducing the glucose concentration from 5mM to 0.1mM disables the pERK1/2 response, but actually 
increases the pSTAT5 response to IL-3. Results are expressed as the median fluorescence intensity of 
phosphorylated STAT5 or ERK1/2 from biological triplicates (n=3; ***, p˂0.001 ; ****, p˂0.0000. Data 





The dependence of signaling on metabolic pathway activity was then analyzed in more detail 
using two inhibitors of cellular metabolism: 2-deoxyglucose (2DG), a competitive inhibitor of 
phosphoglucose isomerase that effectively blocks glycolysis at the second step; and 
rotenone, which inhibits complex I of the mitochondrial electron transport chain and thus 
blocks oxidative phosphorylation.  
 FDCP-Mix cells were first incubated in various concentrations of inhibitors (for 2DG 1mM, 
5mM, 20mM and for rotenone 0.5uM, 1uM and 2uM) in order to determinate the maximum 
concentrations at which viability remained above 50% following overnight incubation. Using 
the chosen concentrations (1mM for 2DG and 1uM for rotenone), fresh FDCP-Mix were then 
incubated for 2 hs and 4 hs before measuring viability and intracellular ATP concentration. 
This showed that the maximal reduction in intracellular ATP concentration was achieved 
after 2 hours, at which time viability remained above 75% (Fig 3-3). 
On the basis of these preliminary tests, inhibitors were then included in the 2 hour period of 
IL-3 deprivation immediately preceding phosflow analysis, in medium containing 5mM 
glucose. Since the kinetics of JAK-STAT and MEK-ERK signaling may differ, phosflow analyses 
were performed on cells fixed at 0, 5, 15 and 30 minutes after re-addition of IL-3 in order to 
be able to distinguish between reductions and delays in activity. As presented in (Fig 3-2), 
the highest levels of both pERK1/2 and pSTAT5 were detected under standard, non-inhibited 
culture conditions at the earliest time point tested of 5 minutes post-stimulation. Consistent 
with previous studies in haematopoietic stem and progenitor cells (Kalaitzidis and Neel 
2008), pERK1/2 increased transiently, with levels returning to near-background within 30 
minutes, while pSTAT5 persisted at a high level up to the 30 minutes time point. 
Pretreatment with 2-DG to restrict glycolytic flux reduced the pERK1/2 signal strength 
without there being an obvious shift in the kinetics. A similar, but less marked effect was 
seen following the inhibition of mitochondrial respiration with rotenone. As expected, the 
combination of both inhibitors effectively blocked the MEK–ERK response to IL-3 completely, 
consistent with an inability to produce sufficient ATP to support kinase activity. This pattern 
suggests that the energy used for MEK-ERK signaling is derived primarily from glycolysis, 
with mitochondrial respiration playing a supportive role.  
The pSTAT5 response to IL-3 differed from the ERK1/2 response in two important aspects: 
Firstly, acute phosphorylation of STAT5 was strongly dependent on mitochondrial function 
rather than on glycolysis. This difference is clearly not consistent with the activity of both 
pathways being dependent on the same pool of free ATP. Secondly, while the combination 
of rotenone and 2DG effectively prevented short term pERK1/2 signaling entirely, there 
remained a distinct pSTAT5 response in the same cells. 
The increase in pSTAT5 levels seen at later time points post-stimulation in rotenone blocked 
cells is likely to reflect a compensatory induction of glycolysis, since it does not occur in the 
presence of 2-DG introduced either during the 2 hour period of IL-3 starvation (Fig 3-2) or 





Fig 3-2 A and B The acute pERK1/2 response to IL-3 (Ras-MAPK pathway) can use energy from glycolysis or 
mitochondrial respiration. The acute pSTAT5 response to IL-3 (JAK-STAT pathway) appears to be particularly 
dependent on energy from mitochondria. When both glycolysis and oxidative phosphorylation are blocked, the 
pERK1/2 response is reduced to zero, while de novo STAT5 phosphorylation is still possible. Note: at the 5 
minutes time point, pSTAT5 levels in Rot inhibited cells were significantly lower than in 2DG-inhibited cells (p 
=0.005, while pERK1/2 levels were similar (p=1.000). Data expressed as the mean± SE.  
 
3.2 IL-3 dependent STAT5 phosphorylation does not correlate with free ATP 
levels 
The ability of the JAK-STAT pathway to respond under conditions that effectively inactivate 
MEK -ERK signaling could simply reflect a requirement for higher levels of ATP to complete 
the longer MEK-ERK kinase cascade. However, the observation that the pERK1/2 and pSTAT5 
responses are differentially reliant on glycolysis and mitochondrial electron transport 
suggests that there may be qualitative rather than quantitative differences in the energy use 






In order to correlate changes in signaling with ATP levels, free ATP was measured in extracts 
of FDCP-Mix cells grown in nutrient rich medium and pre-treated for 2 hours with 2-DG, 
rotenone, or both. The results (Fig 3-3) confirmed that inhibition of glycolysis reduces ATP 
levels more drastically than does inhibition of mitochondrial electron transport. 
  
Fig 3-3 Levels of ATP in FDCP-Mix cells exposed for 2 hours to metabolic inhibitors. FDCP-Mix were exposed to 
2 deoxyglucose (2DG), rotenone (Rot) or a combination of both (n=3 ***, p˂0.001. Data expressed as the 
mean± SD). 
This confirmed that while the pattern of Ras-MAPK pathway activity follows closely that of 
free ATP, activity of the JAK-STAT pathway appears to depend on something other than 
simple ATP concentration. 
3.3 STAT5 phosphorylation at low-energy is dependent on the nucleoside 
diphosphate kinase Nme2 
The maintenance of ATP-dependent kinase activity at low ATP concentration suggests the 
possible involvement of a nucleoside diphosphate kinases (NDPK) activity. NDPKs transfer 
the gamma phosphate from nucleoside triphosphates to nucleoside diphosphates. The 
transfer from ATP to a non-adenosine NDP to generate NTP and ADP is generally considered 
to be the forward reaction. However, this reaction is reversible so that the NDP kinases may 
also take the gamma phosphate from NTPs to regenerate ATP from ADP (Stahl et al. 1991). 
The NDP kinase Nme2 has previously been reported to be overexpressed at the protein level 
in chronic myeloid leukemia, in which Nme2 protein levels correlate closely to the activity of 
BCR/ABL (Tschiedel et al. 2012). Furthermore, the maintenance of Nme2 mRNA but not of 
Nme1 mRNA levels in starved bone marrow cells has been found to correlate with prognosis 
in acute myeloid leukemia (Bach et al., 2012). Since Nme proteins are known to bind directly 
to a variety of targets (Dexheimer et al. 2009; Postel et al. 2009; Postel et al. 1993), it is 
possible that Nme2 is involved in the maintenance of JAK-STAT signaling at low ATP levels by 
recharging local ADP at the expense of other NTPs. To test for a possible requirement for 




an empty vector control to transfect FDCP-Mix cells. Under standard, high energy culture 
conditions, quantitative real time PCR measurement showed a modest (though significant) 
difference in Nme2 mRNA levels between shRNA-expressing and control cells. However, 
glucose restriction resulted in both an increase in Nme2 mRNA level in vector-control cells 
and a reduction in Nme2 shRNA-expressing cells, suggesting that there may be an altered 
turnover of Nme2 mRNA under energy-limiting conditions. 
Functional comparisons of shNme2 and control-transfected populations in terms of 
proliferation rate, colony-forming capacity and differentiation potential revealed marked 
differences, despite the relatively small difference in Nme2 mRNA. Population doubling time 
over the first 3 passages was reduced from 26.9 hrs  in the control to 55.4 hrs in the Nme2 
knock-down cells (Fig 3-4B), while colony forming capacity was reduced by fully 10 fold (Fig 
3-4C) and the erythroid differentiation response was impaired (Fig3-4D).
 
 Fig3-4. The effects of shRNA-mediated Nme2 knockdown in FDCP-Mix cells A. Expression of Nme2 mRNA was 
significantly reduced in the knocked down haemo-progenitor cells (n=3 ;*,p ˂ 0.05; **, p ˂ 0.01;  ***, p ˂ 0.001. 
Data expressed as the mean± SD). B. Reducing of doubling time in knockdown cells up to third passage. C. 
Colony formation was significantly reduced in knockdown cells (n=3;*** p ˂ 0.0001. Data expressed as the 
mean± SD). D. Normal haematopoiesis with a broad spectrum of myeloid and erythroid progenitors (left) in 
control transfected cells compared to the delayed erythroid differentiation seen in Nme2 knockdown cells 
(right). 
Since Nme2 knockout mice show a defect in erythropoiesis (Postel et al. 2009), I also 
compared the differentiation response of control and shNme2 transfected cells by 
transferring the FDCP-Mix cells to media supporting both myeloid and erythroid 
differentiation. As can be seen in (Fig 3-4D), the erythroid differentiation of Nme2 




Nme2 knockdown cultures being predominantly myeloid and both CD71 expression and 
haemoglobin staining appearing much later than in the controls.  
Consistent with the slower proliferation of Nme2 shRNA-expressing cells compared to empty 
vector controls, the shRNA-expressing populations used for the experiments described 
above tended to accumulate GFP-ve cells during culture. For this reason, signaling response 
was assessed in freshly sorted populations of GFP+ve cells (Fig 3-5). Under standard, high 
energy conditions, there was no difference between shRNA- and control vector-transfected 
cells in terms of the degree of IL-3-dependent STAT5 phosphorylation. However, this 
changed under the low energy conditions imposed by pre-treatment with 2DG and 
rotenone. Here, the majority of control cells maintained the capacity to mount a robust 
STAT5 response to IL-3 as noted above, while the Nme2 shRNA-transfected population had 
lost this ability, showing that Nme2 is indeed required for IL-3-dependent STAT5  phosph-
orylation under low-energy conditions. 
 
 Fig 3.5. The effects of metabolic inhibitors on JAK-STAT signaling in Nme2 knockdown FDCP-Mix. The FACS 
plots on the left demonstrate the purity of FACS sorted, GFP+ve population used in the Phosflow analysis 









3.4 Pilot study in Primary UCB (Figures 3-6) 
The studies with FDCP-Mix cells suggest that metabolic environment and metabolic activity 
may indeed influence the balance of signaling in haematopoietic stem and progenitor cells. 
In order to validate these findings in primary cells, the umbilical cord blood MNCs were 
cultured in serum free IMDM medium (contain SCF, IL3, TPO) for 2 days then the cell 
incubated with or without metabolic inhibitors for 2 hours in growth factor depleted 
medium.  
Fig 3-6 The effects of metabolic inhibitors on JAK-STAT signaling in UCB. The FACs plot on the left shows the 
gating strategy for CD34+ve and on right the pSTAT5 signaling. The figure shows a representative result from 3 
independent experiments. Sub population of UCB CD34+ve capable to provoke STAT5 signaling under low 
energy condition (2DG+ROT). 
To check the STAT5 response to IL3 under different metabolic stress, the cells were 
stimulated with human IL3 for 10 minutes prior to phosflow intracellular staining. A sub- 
population of UCB CD34+ve cells even in the energy restricted conditions were able to 
initiate STAT5 signaling. These preliminary results support the previous finding with the 
FDCP-Mix system. Due to the incompatibility of CD38 and CD133 markers with the phosflow 





Section II : Effects of medium osmolarity on the proliferation, clonogenicity 
and differentiation capacity on FDCP-Mix cells. (Figure 3-7) 
3.5. Raising the osmolarity with mannitol does not have the same effect as 
raising the salt concentration 
Previous work has shown sodium chloride (NaCl) supplementation of growth medium to 
decrease proliferation rate and increase the proportion of colony-forming cells in both FDCP-
Mix and primary CD34+ cell cultures (data not shown). To determine whether the observed 
effects result from changes in salt concentration or in osmolarity, FDCP-Mix cells were 
cultured in standard medium (320 mOsm/L) or in medium that had been increased to 360 
mOsm/L using sodium chloride, potassium chloride or the metabolically inert sugar 
mannitol. While salt supplementation decreased proliferation rate and increased colony 
forming activity, confirming previous observations, the supplementation of mannitol to the 
same osmolarity had no such effect (Fig 3-7A). This demonstrates that the positive effects of 
salt-adjusted osmolarity on the maintenance of haematopoietic stem and progenitor cells 
(Couthino et al., 1993) is most likely due to the effects of the salt, rather than to the 
osmolarity. 
  
Fig 3-7 A Increased colony formation depends on salt supplementation rather than increased in osmolarity B. 
JAK-STAT activity is increased with salt supplemented media and with mannitol treatment. (n=3 ;**, p ˂ 0.01;  




Given that increasing salt concentration, but not osmolarity, increases the proportion of 
early, colony-forming progenitors in culture, it was of interest to test whether or not this is 
reflected by an effect on the balance of signaling pathways. To examine this, FDCP-Mix cells 
were cultured for 2 days in standard medium (320mOsm/kg) and in medium in which the 
osmolarity had been adjusted to 360 mOsm/kg using NaCl, KCl or mannitol as described 
above. Following a 2hr period of IL-3 starvation, the response of the JAK-STAT, Ras-MAPK 
and P-I3K–Akt signaling pathways were compared by phosflow analysis of pSTAT5, pERK1/2 
and pAkt 15 minutes after re-stimulation with IL-3. The result, shown in (Fig 3-7B), shows 
that JAK-STAT activity is indeed selectively increased in the salt-supplemented media in 
which the frequency of colony-forming cells was higher. However, the JAK-STAT activity was 
increased still more by supplementation with mannitol, which had been shown to have no 
effect on the frequency of colony forming cells. Increasing osmolarity using either mannitol 
or salt therefore increases the JAK-STAT response relative to that of Ras-MAPK or PI-3-K-Akt 




















Section III : The Effect of nicotinamide on the self-renewal and differentiation 
of haematopoietic progenitor cells (Figures 3-8A-G) 
3.6 Nicotinamide slows proliferation while increasing apoptosis, necrosis and 
myeloid differentiation.  
Nicotinamide can increase the amount of NAD+ and affect a variety of cellular processes (see 
Fig 1-3). NAM has been previously reported both to support granulocyte differentiation 
(Skokowa et al. 2009) and to enrich progenitor cells. It was therefore of interest to 
determine the effects of NAM in the FDCP-Mix system. As an initial test, cells were cultured 
in standard self-renewal conditions (high IL3 and horse serum, 0.03mM NAM) and in the 
same medium supplemented with extra NAM to 1mM, 5mM and 10mM. Cell number and 
viability were assessed every 2 days. FDCP-Mix cultured in differentiation medium (low IL-3, 
GM-CSF, G-CSF, fetal bovine serum and 0.03mM NAM) were included as a control. NAM was 
found to result in a concentration-dependent reduction in the overall rate of proliferation 
(Fig 3-8A). The fractions of viable, apoptotic and necrotic cells in the self-renewal cultures 
containing 0.03, 1 or 5mM NAM were assessed by FACS (Fig 3-8B). Consistent with the 
reduced proliferation, the FACS analysis revealed a concentration dependent increase in the 
frequency of necrotic (Annexin+, PI+) cells, indicating toxicity of NAM at high concentrations. 
However, the frequency of apoptotic cells (Annexin+, PI-) did not match that of necrotic cells. 
In particular, there was a peak in apoptosis at the 6 day time point in self-renewal cultures 
exposed to just 1mM NAM. 
 
Fig 3-8A.  shows the effect of NAM on cell proliferation. NAM reduce the overall rate of proliferation in a 
concentration-dependent manner. (n=3  p ˂ 0.001. Data expressed as the mean± SD ;*SR: Self renewal; diff : 








Fig 3-8B shows the effect of NAM on cell viability . NAM enhance the apoptosis at 1mM (n=3  p ˂ 0.001. Data 




Morphological examination of cytospin and stained cells from 4 day cultures (Fig 3-8C).  
showed maturing monocytes and granulocytes in cultures performed in the presence of 
1mM NAM, despite the absence of added myeloid growth factors. These cells were not seen 
under non-supplemented self-renewal conditions (0.03mM NAM) and scattered in the 
presence of 5mM NAM, in which the cells were extensively vacuolated, consistent with NAM 
cytotoxity at this concentration. NAM therefore appears to support the rapid generation of 
morphologically mature myeloid cells in the absence of external myeloid growth factors GM-
CSF or G-CSF or M-CSF.  
 
Fig 3-8C show the effect of NAM on cells morphology x60 oil.    ,cells with myeloid morphology. 
3.7 NAM reduces the proportion of cycling cells 
The reduced proliferation rate of the FDCP-Mix population seen above could be a result of 
increased cell death and/or an effect of NAM on the cell cycle (Wang et al. 2018). 
Specifically, it may be predicted that the differentiation seen in the presence of 1mM NAM is 
associated with a reduction in cycling, since cell maturation usually occurs after proliferation 
has stopped. To test this, FDCP-Mix cells were cultured in self-renewal conditions for 4 days 
with different NAM concentrations, then after washing step with 1x PBS and fixing, the cells 
were stained with PI shown in (Fig 3-8D), the 1mM NAM concentration strongly reduced the 
proportion of cells in the S/G2/M phases of the cell cycle, and increased the proportion of 
sub-G1 events, which most probably correspond to cells undergoing apoptosis or necrosis. 
Higher NAM concentrations resulted in progressively fewer cells in the S/G2/M phase of the 
cycle. However, the major effect on cell cycle was already seen at the 1mM concentration. 
This pattern suggests that 1mM NAM has a major effect on cell cycle, while inducing 
differentiation and apoptosis, while higher concentrations of NAM are increasingly cytotoxic. 
The shift in the subG1 peak at higher NAM concentrations suggests increasing DNA 









Fig 3-8D shows the effect of NAM on cell cycle. The lower figure shows representative FACs plot from 3 
(0.03mM,1mM and 5mM) or 2 (10mM) independent experiments. NAM concentration strongly reduced the 
proportion of cells in the S/G2/M phases of the cell cycle, and increased the proportion of sub-G1 events. (n=3 
;**, p = 0.002;  ***, p = 0.000. Data expressed as the mean± SD).  
3.8 NAM reduce the erythroid and early progenitors markers without 
alteration in granulocytic markers 
The presence of morphologically distinct granulocytes cells in FDCP-Mix cultures treated 
with NAM but no myeloid growth factors made it interesting to examine the expression of 
surface markers to see whether these are altered accordingly. Therefore, the cells were 




differentiation medium being included as a control. Surface markers were examined by FACS 
every on days 2, 4 and 6 of culture.  
The Gr1 antigen is present on granulocytes and was increased accordingly under 
differentiation conditions peaking at day 4. The following reduction by day 6 is due to death 
of short lived granulocytes. Surprisingly, Gr1 expression in the cultures supplemented with 
1mM NAM was only slightly (and not significantly) above the self-renewal control at day 4 
and there was no increased expression of GR1 detectable at day 2 or day 6. This suggests 
that the morphological myeloid differentiation seen in the absence of added growth factors 
is not accompanied by the increased expression of GR1 typical of cells differentiating in the 
presence of added myeloid growth factors. 
As can be seen in (Fig 3-8E), NAM supplementation did reduce the frequency of cells 
expressing the stem and progenitor marker c-Kit (CD117, stem cell factor receptor, 
expressed on stem and early progenitor cells) as well as the proportion expressing CD71 
(transferrin receptor, expressed predominantly on early erythroid cells) in comparison to 
cells maintained in standard self-renewal conditions. The modest decrease in c-Kit and CD71 
expression even under self-renewal conditions seen during the later stages of culture are 
typical of FDCP-Mix cells that reach a critical cell density. These densities were not reached 
in the NAM-treated or differentiation cultures (not shown). For both c-Kit/CD117 and CD71, 
the reduction in non-myeloid markers was NAM-concentration dependent. In 5mM NAM, 
the reduction in expression was nearly as much as that seen under standard differentiation 





Fig 3-8E shows the effect of NAM on surface markers. Gr1 expression in the cultures supplemented with 1mM 
was only slightly (and not significantly) above the self-renewal control at day4 NAM reduce both C-Kit and 
CD71 during the later stages of culture: (% of CD markers : the proportion of events above a cut off (gate 




3.9 NAM reduce the colonies formation and pSTAT5 signaling 
The concentration-dependent loss of c-Kit under NAM treatment of FDCP-Mix suggests that 
NAM exposure may be causing a loss of stem/progenitor characteristics. To look at 
functional consequences of NAM-exposure in more detail, both the colony-forming potential 
and the JAK-STAT response to IL-3 were determined in FDCP-Mix cells pretreated with NAM 
for 4 days (Fig 3-8F)  
NAM treatment reduced the colony-forming/self-renewal potential of FGDCP-Mix in a 
concentration-dependent manner, comparable with the loss of c-Kit expression, confirming 
that NAM causes loss of stem/early progenitor cell function as well as marker expression.  
 
Fig 3-8F NAM treatment reduced the colony-forming / self-renewal potential of FGDCP-Mix. (n=3 ;p = 0.000. 
Data expressed as the mean± SD).   
 





Similarly, phosflow analysis of the pSTAT5 response of NAM-treated and control cells to IL-3 
clearly showed the pSTAT5 signal to be reduced in NAM concentrations of 1mM or above 
(Fig 3-8G) 
Taken together, these results show that 1mM NAM reduces the pSTAT5 signaling response 
to IL-3, cell cycling and self-renewal potential while initiating an atypical program of myeloid 
differentiation that results in granulocyte-like cells with abnormally low GR1 expression and  
apoptosis. Higher concentrations promote a more marked loss of stem/progenitor 

























4. Discussion  
The fate of HSC and progenitor cells is regulated through both extracellular and intracellular 
factors. The bone marrow niche environment provides specific cellular interactions with 
matrix, including physico-chemical and metabolic environments (Boulais and Frenette 2015; 
Ng and Alexander 2017; Pinho and Frenette 2019). The aims of this study were firstly to 
determine whether cellular metabolism affects the balance between signaling pathways 
affecting self-renewal and differentiation; secondly, to examine the dependence of signaling 
on changes in osmolarity and finally to determine the effects of nicotinamide on the self-
renewal and differentiation of haematopoietic progenitor cells.  
Previous publications have reached conflicting conclusions concerning the influence of 
nicotinamide (NAM) on HSCs/MPPs. On the one hand, a high NAM concentration has been 
shown to enrich for stem cells in cord blood-derived mononuclear cell preparations (Peled et 
al. 2012). On the other hand, NAM used at a somewhat lower concentration supports 
granulocyte differentiation in vitro and in vivo (Skokowa et al. 2009) . The study reported 
here found no evidence that NAM supports undifferentiated stem cells. Rather, the results 
reported here confirm and extend the work of (Skokowa et al. 2009) by showing that NAM 
drives a pattern of granulocyte differentiation that takes place even in the absence of added 
myeloid growth factors. It is possible that this is a result of induction of an autocrine loop of 
G-CSF and G-CSFR via NAD-dependent activation of sirtuin as suggested by (Skokowa et al. 
2009). In this case, the cell cycle block (which was also noted by (Wang et al. 2018)) may be 
part of the differentiation program. Alternatively, the cell cycle block and granulocyte 
differentiation may be independent effects, as suggested by the stronger block without 
more marked differentiation at higher NAM concentrations. This finding suggests that the 
selective enrichment of stem cells in cord blood mononuclear cell preparations that was 
reported by (Peled et al. 2012) may in fact result from a combination of cell cycle block and 
general cytotoxicity to which more differentiated cells are more susceptible.  Further work 
will be necessary to distinguish these effects and to characterize the functionality of the Gr1-
ve granulocytes arising from NAM-induced differentiation in the absence of G-CSF. It will be 
particularly interesting to see whether these cells also arise from primary human progenitors 
treated with NAM in the absence of G-CSF.  
The finding that salt supplementation of media increases the efficiency of FDCP-Mix colony 
formation in semi-solid media provides further evidence that balance between self-renewal 
and differentiation is not either entirely intrinsic or growth factor dependent, but can be 
influenced by other environmental factors. There has been very little published concerning  
the effects of osmolarity or salt concentration on HSCs in-vivo or in-vitro. Although increased 
osmolarity (adjusted with NaCl) has been noted to be advantageous for the maintenance of 
stem cells in long term culture (Coutinho et al 1993), it is not clear why a relatively small 
change in the salt concentration should have such a marked effect on the cells. A possible 
explanation for this phenomena may be the influence of the high salt concentration on 




amino acid uptake, which may in turn affect the cell metabolism and somehow favor the 
self-renewal capacity (Yamazaki and Nakauchi 2015). Alternatively, the observed effects may 
be due to high salt being a  particular disadvantage for maturing cells, that may be more 
sensitive to osmotic stresses (Ting-Beall et al. 1993).  
It is particularly interesting that an increase in osmolarity caused either by salt or by 
mannitol increases the pSTAT5 response to IL-3. Since STAT5 signaling is associated with self-
renewal rather than differentiation, this may provide an explanation for the increased 
colony formation in high salt media. In this case, however, it is unclear why colony formation 
was not increased in high mannitol medium. It is possible that this is due to a different 
duration of the increased signaling following the change in osmolarity and it would be 
interesting to compare the duration of the increased pSTAT5 response under high salt and 
high mannitol to distinguish between short term and long term responses. 
Importantly, it is shown here that the balance of signals transduced from the IL-3 receptor in 
haematopoietic progenitor cells can be influenced by the metabolic environment and the 
energetic state of the cell. Reducing glucose reduces the Ras-MAPK response to IL-3 but 
actually increases the JAK2-pSTAT5 response. The high pSTAT5 signal under low intracellular 
ATP may in theory be either a part of programed cell death or autophagy (Majri et al. 2018; 
Altman and Rathmell 2012; Elmore 2007). However, due to the short time of incubation with 
metabolic inhibitors or low glucose before the Phosflow analysis (Fig3.1-3.3), this is unlikely 
to be the case here. It is more likely that a short term change in the pattern of metabolism 
shifts the relative activities of the JAK-STAT and Ras-MAPK pathways, so that self-renewal 
JAK-STAT signaling is favored at low energy levels. Interestingly, other signaling pathways 
associated with the maintenance and self-renewal of stem cells such as those of Wnt, Notch, 
Hedgehog and TGFß (Warr et al. 2011) also tend to be short and direct, and most probably 
require less energy than do the multi-stage kinase cascades such as the Ras-MAPK and PI3K-
mTOR pathways that drive proliferation and differentiation. 
It should be noted that a low energy metabolic stem cell niche might not just support the 
self-renewal rather than the differentiation of stem cells, but could also contain their 
potentially tumorigenic self-renewal potential. Firstly, if active stem cells within a low-energy 
niche are ready to differentiate but are prevented from doing so by limiting energy, then any  
cell leaving the niche would immediately activate differentiation pathways and differentiate. 
Secondly, a niche in which the rate of stem cell self-renewal is metabolically restricted avoids 
selection for cells with mutations in receptors, signal transducers, transcription factors or 
cell cycle control machinery that would otherwise have given a selective advantage to a 
mutated stem cell clone. In this way, a metabolic niche could guard against the emergence 
of abnormal clones (Cross et al. 2008). 
The observed towards JAK-STAT signaling at low energy levels poses the question of how this 
is achieved. The simplest explanation would be that the maintenance of JAK2-STAT5 




Hypothesis). However, the situation appears not to be this simple, since the activities of the 
two pathways did not appear to be dependent on the same pool of free ATP, Ras-MAPK 
being dependent on glycolysis while JAK-STAT5 signaling was more dependent on 
mitochondrial metabolism. The direct measurement of the ATP pool confirmed that JAK-
STAT signaling was more dependent on mitochondrial function than on ATP concentration, 
indicating a qualitative difference in the way that these pathways are fueled. 
 
Fig4.1 The JAK- STAT5 pathway requires less ATP than the RAS-MAPK  pathway. The upper panel shows the 
situation at high energy levels. Both the JAK-STAT and Ras-MAPK pathways have sufficient ATP and activity is 
dependent on the level of IL-3 bound receptor. The lower panel shows the siutaion at low energy levels. 
It therefore seems likely that the JAK-STAT pathway can be maintained by a specific reaction 
that is not available to the Ras-MAPK pathway. The most obvious candidate reaction is the 
local regeneration of ATP from ADP and an NTP by a nucleoside diphosphate kinase (NDP 
Kinase). The local recharging of NTPs via NDP Kinases has been suggested to maintain 
enzyme activity in similar situations, and although the emphasis to date has been on 
regenerating GTP using ATP the simple reversibility of the NDPK reaction makes the 
regeneration of ATP using some other NTP equally feasible (see Fig 4.2) (Stahl et al. 1991; 




metabolism but not by glycolysis, this may explain why JAK-STAT signaling in low energy 
FDCP-Mix is more dependent on mitochondrial than on glycolytic metabolism. 
 
Fig4.2 The energy restriction supports selective STAT5 phosphorylation via local ATP regeneration by NDPKB.  
Nucleoside diphosphate kinase B also known as Nme2/Nm23H2, Nm23B, NDKB and PUF is 
an enzyme that in humans is coded by the nme2 gene. Nme1 (NDPKA) and Nme2 (NDPKB) 
show 88% amino acid sequence similarity and are located in the same region of 
chromosome 17q21 (Stahl et al. 1991). The Nme2 protein has a nucleotide-binding site, 
kinase activity and also a DNA binding site which is independent from the other domains 
(Dexheimer et al. 2009). One of the main functions of Nme2 is to transfer the gamma 
phosphate group from ATP to non-adenosine NDPs to generate NTP or vice versa. 
Furthermore, Nme2 also acts as a transcriptional activator of c-myc (Postel et al. 1993). 
Importantly, both Nme1 and Nme2 have been described as differentiation inhibitory factors 
in AML and CML (Okabe-Kado et al. 1998; Yokoyama et al. 1996).  
The knockdown of Nme2 in FDCP-Mix cells by transfection with a lentiviral shRNA expression 
vector confirmed that Nme2 is required to maintain a high level of JAK2-STAT5 signaling 
under low energy conditions. This demonstrates the existence of a refined NDPK-dependent 
mechanism allowing specific kinases to draw on energy reserves that are not available to 
other pathways. Knocking down the Nme2 reduced the pSTAT5 signaling only when the cells 
were under metabolic stress. In this regard, it is interesting that glucose restriction resulted 
in both an increase in Nme2 mRNA level in vector-control cells and a more marked reduction 
in Nme2 shRNA-expressing cells, suggesting that there may be an induction of Nme2 
expression as well as increased turnover under energy-limiting conditions. The regulation of 
the Nme2 gene does indeed seem to be complex: a marked reduction in mRNA following 
transient transfection with shRNA expression plasmid leads to a rapid compensatory 
upregulation of the mRNA (Enrica Bach and Michael Cross, personal communication). Also, 
previous studies by (Tschiedel et al. 2012) found the expression of the fusion oncoprotein 
BCR-ABL in chronic myeloid leukemia to be accompanied by an extreme accumulation of 
Nme2 protein in the cytoplasm even though mRNA was barely detectable under these 
conditions, while the situation in AML is quite the opposite with high levels of Nme2 mRNA 
in the absence of detectable protein (Bach et al. 2012). These observations, together with 
the presence of Nme2 binding sites in the Nme2 gene promoter region, (Postel et al. 1993; 
Okabe-Kado et al. 1998; Yokoyama et al. 1996) suggest that Nme2 expression is most 




While it is possible that Nme2 plays a role in stem cell maintenance under non-laboratory 
conditions, there is no obvious stem cell or myeloid defect in Nme2 knockout mice under 
laboratory conditions. However, there was a marked defect in erythropoiesis in the Nme2 
knockout mice (Postel et al. 2009) that was confirmed using FDCP-Mix cells in the current 
study. This suggests that Nme2-mediated focusing of energy resources may be involved in 
maintaining the viability and/or the undifferentiated state of erythroid progenitors, perhaps 
by interacting with signaling from the EPO receptor which, like the IL-3 receptor, also signals 
through JAK2-STAT5 (Joosten et al. 2004). 
Given the reported association between Nme2 expression and the type and prognosis of 
myeloid leukemia and the obvious interest in the underlying mechanisms, it was 
encouraging to find that a proportion of normal human CD34+ progenitors show an ability to 
maintain JAK-STAT5 signalling under low-energy conditions similar to the murine FDCP-Mix 
cells. It will particularly important in the future to determine the relevance of Nme2 
expression to the ability of normal and leukemic progenitors to survive and self-renew at low 
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The adult human blood system is maintained by replacement of more than 1011 cells per day 
through continuous haematopoiesis: A hierarchical differentiation and proliferation system 
in the bone marrow. At the top of the hierarchy are haematopoietic stem cells (HSCs) that 
cycle slowly to generate on average one replacement HSC and one multipotent progenitor. 
The multipotent progenitors then proliferate more rapidly, generating daughter cells that 
follow programs of commitment to the lymphoid, myeloid or erythroid lineages. Under some 
conditions (during development or after damage), the pool of HSCs can be increased by 
symmetric divisions in which one stem cell produces two (Nakamura-Ishizu et al. 2014; Ng 
and Alexander 2017; Pinho and Frenette 2019). 
 It is important to understand the mechanisms regulating the production of blood cells 
(Haematopoiesis) in the bone marrow, in order to improve the diagnosis of haematological 
disease and to identify new opportunities for therapy. 
The major focus to date has been firstly on the genes that control survival, differentiation 
and proliferation and that are commonly mutated in haematological disease, and secondly 
on a range of growth factors that are provided in the haematopoietic cell environment and 
can affect these processes by activating specific receptors.  
At the same time it has been realized that the haematopoietic bone marrow is an organized 
structure in which haematopoiesis is arranged in specific areas or niches, at various 




Scadden 2014; Kumar et al. 2018). This organization suggests that the metabolic 
environment, including the availability of nutrients and oxygen as well as variation in 
osmolarity and pH, may vary with position and may therefore play a role in organizing and 
maintaining haematopoiesis. 
Here, three aspects of the influence of the metabolic environment on the biology of 
haematopoietic progenitor cells have been investigated using a multipotent murine 
progenitor cell culture system (FDCP-Mix) that reproduces many features of normal 
progenitor cell self-renewal and differentiation. 
Firstly, following up on conflicting reports that nicotinamide (NAM, a form of vitamin B3) can 
maintain self-renewing stem cells on the one hand but on the other hand increases 
granulocyte differentiation (Skokowa et al. 2009; Peled et al. 2012) , it was shown that NAM 
does not support self-renewing FDCP-Mix, but does support granulocyte differentiation. 
Surprisingly, the addition of NAM in the absence of added myeloid growth factors is 
sufficient to generate granulocyte-like cells. However, these granulocytes appear to lack the 
expression of the granulocyte-specific surface marker Gr1. This suggests that NAM can 
initiate a program of differentiation, but completion of the program requires an external 
source of G-CSF. It is unclear whether NAM concentrations change significantly in the bone 
marrow at different locations or at different times.   
Secondly, the effects of osmolarity on self-renewal and differentiation were investigated, 
since osmolarity is likely to vary within haematopoietic marrow and has been previously 
reported to affect the maintenance and function of stem cells (Coutinho et al 1993). It was 
found that the positive effects of high osmolarity on the maintenance of multipotent 
progenitor FDCP-Mix are seen only when osmolarity is raised by the addition of salt (sodium 
chloride or potassium chloride) and not when raised by the addition of the inert sugar 
mannitol. This suggests that high salt, rather than osmolarity alone, favors self-renewing 
cells over differentiating cells. Potential mechanisms include the activation of amino acid 
transporters, effects on metabolism and/or signaling. Interestingly, high salt increased the 
level of JAK2-STAT5 signaling via the IL-3 receptor, which is associated with self-renewal 
rather than differentiation. However, a similar effect was seen in high mannitol, at least in 
the short term, meaning that a short term increase in the JAK-STAT response is not sufficient 
to favor self-renewing cells over differentiating cells in the FDCP-Mix system. 
Thirdly, a more detailed analysis of the dependence of signaling activities on metabolism 
was carried out by comparing the JAK-STAT and Ras-MAPK (Erk1/2) response of FDCP-Mix to 
IL-3. Here, it was found that a simple decrease in the glucose concentration of the medium 
resulted in a shift towards JAK-STAT signaling. By using selective inhibitors of glycolysis and 
mitochondrial electron transport, it was further demonstrated that Ras-MAPK pathway 
activity varies with the concentration of free ATP and is largely dependent on glycolysis. In 
contrast, JAK-STAT pathway activity was maintained at low ATP levels and was mainly 




two pathways do not rely equally on the same energy source. These observations led to the 
hypothesis that the JAK-STAT pathway may be maintained by the activity of a nucleoside 
diphosphate kinase that can regenerate ATP from ADP locally by transferring the gamma 
phosphate from GTP. In support of this hypothesis, a requirement for the NDP kinase Nme2 
was demonstrated by knockdown of endogenous Nme2 in FDCP-Mix cells using a shRNA 
lentivirus construct. Reduction of the Nme2 level led to a reduction in the JAK-STAT signaling 
activity under low-energy conditions, while signaling under high energy conditions was not 
affected. This demonstrates a previously unidentified link between signaling and metabolism 
that is likely to be relevant for the maintenance of stem cell fate in low energy niches. The 
previously reported overexpression of Nme2 protein in chronic myeloid leukemia progenitor 
cells and the association of Nme2 mRNA expression with prognosis in acute myeloid 
leukemia underline the probable relevance of Nme2 to the maintenance of stem cells in low-
energy niches in both normal and leukemic haematopoiesis. 
This work shows how the nutrient and physico-chemical environment can indeed affect the 
self-renewal versus differentiation of haematopoietic progenitor cells in vitro, consistent 
with the proposed existence of metabolic niches in vivo that contribute to the organization 
and control of haematopoiesis. The identification of Nme2 as a key link between metabolic 
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